K. Zadina

发表

Starting Aspirin Therapy After Operation: Effects on Early Graft Patency

J. Copeland, K. Kern, W. Henderson, 1991, Circulation.

STARTING ASPIRIN THERAPY AFTER OPERATION. AUTHOR'S REPLY

S. Rezkalla, W. Henderson, S. Goldman, 1992 .

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.

Robert J Anderson, Steven Goldman, Robert J. Anderson, 2004, Journal of the American College of Cardiology.

Comparison of postoperative complications between saphenous vein and IMA grafts to left anterior descending coronary artery.

Thomas E. Moritz, J. Copeland, W. Henderson, 1991, The Annals of thoracic surgery.

Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study.

Thomas E. Moritz, J. Copeland, K. Kern, 1994, Circulation.

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.

Thomas E. Moritz, J. Copeland, W. Henderson, 1988, Circulation.

Effects of Aspirin 0130 BLEEDING COMPLICATIONS IN TREATMENT WITH ASA AND ANTICOAGULANTS

J. Copeland, K. Kern, W. Henderson, 2005 .

Comparison of postoperative comlications between saphenous vein and IMA grafts to left anterior descending coronary artery.

J. Copeland, W. Henderson, G. Sethi, 1991, The Annals of thoracic surgery.

Affairs Cooperative Study after coronary artery bypass surgery: Results from a Department of Veterans Long-term patency of saphenous vein and left internal mammary artery grafts

Thomas E. Moritz, Lizy Thottapurathu, G. Sethi, 2011 .

Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery

Thomas E. Moritz, S. Goldman, K. Zadina, 2004 .

Plasma Angiotensin-Converting Enzyme Activity and Carotid Wall Thickening

R. Califf, D. Paterson, E. Topol, 2005 .

Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Surgery and Effects of Antiplatelet Therapy

J. Copeland, W. Henderson, G. Sethi, 2005 .

Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.

Thomas E. Moritz, J. Copeland, W. Henderson, 1990, Journal of the American College of Cardiology.

Predictors of graft patency 3 years after coronary artery bypass graft surgery. Department of Veterans Affairs Cooperative Study Group No. 297.

Thomas E. Moritz, J. Copeland, W. Henderson, 1997, Journal of the American College of Cardiology.

The statistical analysis of graft patency data in a clinical trial of antiplatelet agents following coronary artery bypass grafting.

W G Henderson, Thomas E. Moritz, J. Copeland, 1988, Controlled clinical trials.

Internal mammary artery and saphenous vein graft patency. Effects of aspirin.

Thomas E. Moritz, J. Copeland, K. Kern, 1990, Circulation.

Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

J. Copeland, W. Henderson, G. Sethi, 1989, Circulation.

1079-87 Predictors of 10-year patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a department of veterans affairs cooperative study

Robert J. Anderson, Thomas E. Moritz, Lizy Thottapurathu, 2004 .

Predictors of Graft Patency 3 Years After Coronary Artery Bypass Graft Surgery fn1fn1This research was supported by the Cooperative Studies Program of the Medical Research Service, Department of Veterans Affairs Central Office, Washington, D.C.

Thomas E. Moritz, J. Copeland, W. Henderson, 1997 .